Acurx Pharmaceuticals is a clinical-stage company developing new classes of antibiotics to treat severe bacterial infections like C. difficile and MRSA. Their lead product candidate is currently undergoing clinical trials to test its effectiveness against specific bacterial enzymes. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
